MacroGenics
MGNX
163 hedge funds and large institutions have $954M invested in MacroGenics in 2024 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 55 increasing their positions, 50 reducing their positions, and 19 closing their positions.
1,040% more call options, than puts
Call options by funds: $15.6M | Put options by funds: $1.37M
116% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 19
59% more capital invested
Capital invested by funds: $598M → $954M (+$355M)
15% more funds holding
Funds holding: 142 → 163 (+21)
10% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 50
3.55% more ownership
Funds ownership: 100.29% → 103.83% (+3.5%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACA
Avoro Capital Advisors
New York
|
+$93M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$36.4M |
| 3 |
State Street
Boston,
Massachusetts
|
+$33.5M |
| 4 |
VPC
Vestal Point Capital
New York
|
+$11M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$6.83M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$43.4M |
| 2 |
AC
Armistice Capital
New York
|
-$32.8M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$29.8M |
| 4 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$11.8M |
| 5 |
Millennium Management
New York
|
-$11.6M |
MGNX Hedge Fund Activity: Q1 2024 in Review
163 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q1 2024, worth a combined $954M — up 59% from $598M a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new MGNX positions and 19 closed out — a net gain of 22 holders — while 55 added to existing stakes and 50 trimmed.
The largest buyer was Avoro Capital Advisors, opening a new position worth an estimated $93M. The largest seller was T. Rowe Price Investment Management, cutting an estimated $43.4M.
- 163 institutional investors held MacroGenics (MGNX) as of Q1 2024, up from 142 in Q4 2023.
- Funds reported $954M of MacroGenics stock for Q1 2024, up 59% quarter-over-quarter.
- 41 funds opened new MacroGenics positions in Q1 2024 and 19 closed out, a net change of +22 holders.
- The largest MacroGenics buyer in Q1 2024 was Avoro Capital Advisors, an estimated $93M added.
- The largest MacroGenics seller in Q1 2024 was T. Rowe Price Investment Management, an estimated $43.4M sold.
Based on aggregated 13F filings for Q1 2024.